Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Apr. 10, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is plaintiff Allergan, Inc.’s Motion to Compel Compliance with Subpoena, Dkt. No. 291, which seeks to compel third party Alcon Laboratories, Inc., to produce a set of previously identified documents .1 In its response, Alcon has opposed the motion but requested that, in the event the Court grants the motion, the Court also order that Allergan pay Alcon’s expenses regarding the subpoena , including attorney s’ fees. Allergan’s motion is GRANTED, and Alcon’s conditional cross-motion is DENIED without prejudice.